Champlain discloses 4.9% stake in SI-BONE
Champlain Investment Partners, LLC reported beneficial ownership of 2,108,944 shares of SI-BONE, Inc. common stock, representing 4.9% of the class as of 09/30/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Champlain Investment Partners, LLC reported beneficial ownership of 2,108,944 shares of SI-BONE, Inc. common stock, representing 4.9% of the class as of 09/30/2025. Champlain has sole voting power over 1,337,489 shares and sole dispositive power over 2,108,944 shares, with no shared voting or dispositive power.
The firm files as an institutional investment adviser and certifies that the shares were acquired and are held in the ordinary course of business, not for the purpose or effect of changing or influencing control of SI-BONE, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Champlain Investment Partners’ Schedule 13G for SIBN show?
Is Champlain Investment Partners seeking to influence control of SI-BONE (SIBN)?
Why is Champlain Investment Partners filing a Schedule 13G on SIBN?
What percentage of SI-BONE (SIBN) does Champlain’s stake represent?
AI-generated analysis. How Rhea-AI works. Not financial advice.